These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9853695)

  • 1. Estimating imprecision profiles in biochemical analysis.
    Berweger CD; Müller-Plathe F; Hänseler E; Keller H
    Clin Chim Acta; 1998 Oct; 277(2):107-25. PubMed ID: 9853695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computer program for estimating imprecision characteristics of immunoassays.
    Sadler WA; Smith MH
    Comput Biomed Res; 1990 Apr; 23(2):105-14. PubMed ID: 2335070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating precision--how many measurements do we need?
    ÅSberg A; Solem KB; Mikkelsen G
    Scand J Clin Lab Invest; 2015 Oct; 75(6):496-9. PubMed ID: 26083607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new look at the limits of detection (LD), quantification (LQ) and power of definition (PD).
    Gautschi K; Keller B; Keller H; Pei P; Vonderschmitt DJ
    Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):433-40. PubMed ID: 8399783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical requirements and standardization of CA 15-3.
    van Dalen A
    Scand J Clin Lab Invest Suppl; 1995; 221():102-4. PubMed ID: 7652484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals.
    Røraas T; Petersen PH; Sandberg S
    Clin Chem; 2012 Sep; 58(9):1306-13. PubMed ID: 22761475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of average of normals (AON) procedure for outlier-free datasets including qualitative values below limit of detection (LoD): an application within tumor markers such as CA 15-3, CA 125, and CA 19-9.
    Usta M; Aral H; Mete Çilingirtürk A; Kural A; Topaç I; Semerci T; Hicri Köseoğlu M
    Scand J Clin Lab Invest; 2016 Nov; 76(7):553-560. PubMed ID: 27687786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System.
    Christenson RH; Cervelli DR; Sterner J; Bachmann LM; Rebuck H; Gray J; Kelley WE
    Clin Biochem; 2011 Sep; 44(13):1128-1136. PubMed ID: 21704611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and abuse of imprecision profiles: some pitfalls illustrated by computing and plotting confidence intervals.
    Sadler WA; Smith MH
    Clin Chem; 1990 Jul; 36(7):1346-50. PubMed ID: 2372950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mathematical procedure for the assessment of test performance of PSA assays.
    Hänseler E; Keller H
    Scand J Clin Lab Invest Suppl; 1995; 221():52-6. PubMed ID: 7544485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computer program for variance function estimation, with particular reference to immunoassay data.
    Sadler WA; Smith MH
    Comput Biomed Res; 1987 Feb; 20(1):1-11. PubMed ID: 3829638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new WIN32 computer program for estimating immunoassay variance functions.
    Sadler WA
    Comput Methods Programs Biomed; 2002 Mar; 67(3):195-9. PubMed ID: 11853945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of algorithm for quantification of regional myocardial blood flow using 15O-water with PET.
    Katoh C; Morita K; Shiga T; Kubo N; Nakada K; Tamaki N
    J Nucl Med; 2004 Nov; 45(11):1908-16. PubMed ID: 15534062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variance and confidence limits in validation studies based on comparison between three different types of measurements.
    Ferrari P; Kaaks R; Riboli E
    J Epidemiol Biostat; 2000; 5(5):303-13. PubMed ID: 11142606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Error models for immunoassays.
    Sadler WA
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):481-5. PubMed ID: 18753420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer.
    Findeisen R; Albrecht S; Richter B; Deutschmann K; Distler W
    Clin Chem Lab Med; 1998 Nov; 36(11):841-6. PubMed ID: 9877089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive and reliable detection of CA15-3 in patient plasma with electrochemical biosensor labeled with magnetic beads.
    Akbari Nakhjavani S; Khalilzadeh B; Samadi Pakchin P; Saber R; Ghahremani MH; Omidi Y
    Biosens Bioelectron; 2018 Dec; 122():8-15. PubMed ID: 30236808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the variance function to estimate limit of blank, limit of detection and their confidence intervals.
    Sadler WA
    Ann Clin Biochem; 2016 Jan; 53(Pt 1):141-9. PubMed ID: 25678668
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.